Product Information

ORPHENADRINE ER 100 MG TABLET is a generic product labeled by Sandoz Inc., priced at $0.4586 per EA under NDC 00185002201. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Feb 15, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ORPHENADRINE ER 100 MG TABLET

Orphenadrine Citrate
$0.4586per EA

Strength

100 mg/1

Manufacturer

Sandoz Inc.

NDC

00185002201

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ORPHENADRINE CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA040327

FDA Approved

2/15/2000

TE Code

AB

On Market Since

2/15/2000

Pharmacological Classes

Centrally-mediated Muscle Relaxation
Muscle Relaxant

Price Statistics

The NADAC for ORPHENADRINE ER 100 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 23.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4586 per EA
All-time high$0.5364 (Dec 14, 2022)
All-time low$0.2632 (Jan 22, 2020)
52-week high$0.4750
52-week low$0.4280
Median price$0.3891
Average price$0.3871
Largest weekly change+70.2% (Aug 19, 2020)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.8%

1M

-0.8%

3M

+0.2%

6M

+2.8%

1Y

+7.1%

3Y

+3.1%

5Y

+36.5%

All

+23.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Orphenadrine Citrate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ORPHENADRINE ER 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ORPHENADRINE ER 100 MG TABLET, manufactured by Sandoz Inc., is $0.4586 per EA (NDC 00185002201), effective Aug 19, 2026.

How has the price of ORPHENADRINE ER 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for ORPHENADRINE ER 100 MG TABLET has risen 23.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ORPHENADRINE ER 100 MG TABLET?

Since Nov 28, 2013, the NADAC for ORPHENADRINE ER 100 MG TABLET has ranged from a low of $0.2632 (Jan 22, 2020) to a high of $0.5364 (Dec 14, 2022), with a median of $0.3891 per EA.

Are there cheaper alternatives to ORPHENADRINE ER 100 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ORPHENADRINE ER 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ORPHENADRINE ER 100 MG TABLET?

ORPHENADRINE ER 100 MG TABLET (NDC 00185002201) is labeled by Sandoz Inc., and CMS classifies it as a generic product.